Overview FIRDAPSE. The outcome of patent litigation with Paragraph IV challengers is always uncertain and there can be no assurance as to whether we will prevail in this litigation. Other Litigation From time to time we may become involved in legal proceedings arising in the ordinary course of business. Other than as set forth above, we believe that there is no litigation pending at this time that could have, individually or in the aggregate, a material adverse effect on our results of operation...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-071525 | EDGAR | 94K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027714 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001193125-24-050908 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001193125-23-071299 | EDGAR | — |
| 2022-03-16 | 2021-12-31 | 0001193125-22-077228 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001193125-21-081545 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001193125-20-075048 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001193125-19-078253 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001193125-18-082292 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001193125-17-083667 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-266854 | EDGAR | 38K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104000 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065652 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122282 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092745 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001193125-24-134195 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001193125-23-273506 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001193125-23-207344 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001193125-23-140701 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001193125-22-281202 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001193125-22-216148 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001193125-22-146274 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-18 | 0001193125-26-114306 | EDGAR | 0K words |
| 2026-02-25 | 0001193125-26-071702 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009822 | EDGAR | — |
| 2025-11-05 | 0001193125-25-267038 | EDGAR | — |
| 2025-10-01 | 0001193125-25-226837 | EDGAR | — |
| 2025-08-25 | 0001193125-25-187733 | EDGAR | — |
| 2025-08-07 | 0001193125-25-175477 | EDGAR | — |
| 2025-08-06 | 0001193125-25-174540 | EDGAR | — |
| 2025-08-04 | 0001193125-25-172653 | EDGAR | — |
| 2025-06-02 | 0001193125-25-133348 | EDGAR | — |
329 total filings indexed. 297 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001369568 |
| Ticker | CPRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.catalystpharma.com |
| Listed | 2006-11-08 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report